title: Combinative in vitro studies and computational model to predict 3D cell migration response to drug insult.
abstract: The development of drugs to counter diseases related to cell migration has resulted in a multi-billion dollar endeavor. Unfortunately, few drugs have emerged from this effort highlighting the need for new methods to enhance assays to study, analyze and control cell migration. In response to this complex process, computational models have emerged as potent tools to describe migration providing a high throughput and low cost method. However, most models are unable to predict migration response to drug with direct application to in vitro experiments. In addition to this, no model to date has attempted to describe migration in response to drugs while incorporating simultaneously protein signaling, proteolytic activity, and 3D culture. In this paper, we describe an integrated computational approach, in conjunction with in vitro observations, to serve as a platform to accurately predict migration in 3D matrices incorporating the function of matrix metalloproteinases (MMPs) and their interaction with the Extracellular signal-related kinase (ERK) signaling pathway. Our results provide biological insight into how matrix density, MMP activity, integrin adhesions, and p-ERK expression all affect speed and persistence in 3D. Predictions from the model provide insight toward improving drug combinations to more effectively reduce both speed and persistence during migration and the role of integrin adhesions in motility. In this way our integrated platform provides future potential to streamline and improve throughput toward the testing and development of migration targeting drugs with tangible application to current in vitro assays.
authors.affiliation: Department of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, Massachusetts 02215, USA.
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Maffei
authors.forename: Jaya
authors.initials: J
authors.lastname: Srivastava
authors.forename: Brian
authors.initials: B
authors.lastname: Fallica
authors.forename: Muhammad H
authors.initials: MH
authors.lastname: Zaman
mesh_terms: D000577:Amides / Q000494:pharmacology; D002070:Butadienes / Q000494:pharmacology; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology*; D003198:Computer Simulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005109:Extracellular Matrix / Q000502:physiology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D015151:Immunoblotting; D066298:In Vitro Techniques; D020782:Matrix Metalloproteinases / Q000502:physiology*; D018613:Microscopy, Confocal; D008962:Models, Theoretical; D009570:Nitriles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D000577:Amides; D002070:Butadienes; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D009570:Nitriles; D011725:Pyridines; D034741:RNA, Small Interfering; C113580:U 0126; C108830:Y 27632; C100342:marimastat; D048049:Extracellular Signal-Regulated MAP Kinases; D020782:Matrix Metalloproteinases